Qube Research & Technologies LTD Meridian Bioscience Inc Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $4.71 Million - $5.05 Million	151,133 Added 60.01%	402,964 $13.4 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $7.11 Million - $7.72 Million	230,026 Added 1054.92%	251,831 $7.94 Million
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $517,868 - $691,000	21,805 New	21,805 $663,000
Q1 2020 May 15, 2020	SELL	$5.57 - $11.5 $220,248 - $454,733	-39,542 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$7.9 - $10.14 $312,381 - $400,955	39,542 New	39,542 $386,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.